The emerging treatment of tirzepatide peptide represents a major development in the care of type 2 diabetes. Different to existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide078133.onzeblog.com/42202915/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment